Safety and immunogenicity of the intranasal H3N2 M2-deficient single-replication influenza vaccine alone or coadministered with an inactivated influenza vaccine (Fluzone High-Dose Quadrivalent) in adults aged 65–85 years in the USA: a multicentre, randomised, double-blind, double-dummy, phase 1b trial-Reference-Cited by-同舟云学术

Safety and immunogenicity of the intranasal H3N2 M2-deficient single-replication influenza vaccine alone or coadministered with an inactivated influenza vaccine (Fluzone High-Dose Quadrivalent) in adults aged 65–85 years in the USA: a multicentre, randomised, double-blind, double-dummy, phase 1b trial

Published:2024-07 Issue: Volume: Page:
ISSN:1473-3099
Container-title:The Lancet Infectious Diseases
language:en
Short-container-title:The Lancet Infectious Diseases

Author:

Eiden Joseph,Fierro Carlos,White Alexander,Davis Matthew,Rhee Margaret,Turner Mark,Murray Bryan,Herber Renee,Aitchison Roger,Marshall David,Moser Michael J,Belshe Robert,Greenberg Harry,Coelingh Kathleen,Kawaoka Yoshihiro,Neumann Gabriele,Bilsel Pamuk

Funder

US Department of Defense

Publisher

Elsevier BV

Reference28 articles.

1. The immune response to influenza in older humans: beyond immune senescence;McElhaney;Immun Ageing,2020

2. Vaccine effectiveness against influenza A—associated hospitalization, organ failure, and death: United States, 2022–2023;Lewis;Clin Infect Dis,2023

3. Estimates of mortality associated with seasonal influenza for the European Union from the GLaMOR project;Paget;Vaccine,2022

4. Comparative immunogenicity of enhanced seasonal influenza vaccines in older adults: a systematic review and meta-analysis;Ng;J Infect Dis,2019

5. Effectiveness of MF59-adjuvanted seasonal influenza vaccine in the elderly: a systematic review and meta-analysis;Domnich;Vaccine,2017

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Human vaccines and immunotherapeutics: News July 2024;Human Vaccines & Immunotherapeutics;2024-08-14